(19)
(11) EP 3 870 598 A1

(12)

(43) Date of publication:
01.09.2021 Bulletin 2021/35

(21) Application number: 19805437.1

(22) Date of filing: 23.10.2019
(51) International Patent Classification (IPC): 
C07K 14/28(2006.01)
(86) International application number:
PCT/US2019/057721
(87) International publication number:
WO 2020/086758 (30.04.2020 Gazette 2020/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.10.2018 US 201862749489 P
19.12.2018 US 201862781898 P
04.01.2019 US 201962788499 P
01.04.2019 US 201962827347 P
04.09.2019 US 201962895889 P

(71) Applicant: Dragonfly Therapeutics, Inc.
Waltham, MA 02451 (US)

(72) Inventors:
  • CHEUNG, Ann, F.
    Lincoln, MA 01773 (US)
  • CUILLEROT, Jean-Marie
    Somerville, MA 02143 (US)
  • GRINBERG, Asya
    Lexington, MA 02421 (US)
  • GUTIERREZ, Eva
    Waltham, MA 02451 (US)
  • HANEY, William
    Wayland, MA 01778 (US)
  • WAGTMANN, Nicolai
    Concord, MA 01742 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) HETERODIMERIC FC-FUSED PROTEINS